Correction to ‘Producing a preference-based quality of LIFE measure to quantify the impact of HYPOGLYCAEMIA on people living with diabetes: A mixed-methods research protocol’ Carlton, J, Powell, P, Rowen, D, Broadley, M, Pouwer, F, Speight, J, Heller, S, Gall, MA, Rosilio, M, Child, CJ, Comins, J, McCrimmon, RJ, Galan, B, Brazier, J; Hypo-RESOLVE CONSORTIUM. Producing a preference-based quality of LIFE measure to quantify the impact of HYPOGLYCAEMIA on people living with diabetes: a mixed-methods research protocol. Diabet Med 2023 Mar; 40(3):e15007. doi: 10.1111/dme.15007.

IF 3.2 3区医学 Q2 ENDOCRINOLOGY & METABOLISM

Diabetic Medicine Pub Date : 2024-06-05 DOI:10.1111/dme.15351

引用次数: 0

对 "制定基于偏好的生活质量衡量标准，量化低血压对糖尿病患者的影响：A mixed-methods research protocol'Carlton J, Powell P, Rowen D, Broadley M, Pouwer F, Speight J, Heller S, Gall MA, Rosilio M, Child CJ, Comins J, McCrimmon RJ, de Galan B, Brazier J; Hypo-RESOLVE CONSORTIUM.制定基于偏好的生活质量衡量标准，量化低血糖对糖尿病患者的影响：混合方法研究方案。Diabet Med 2023 Mar;40(3):e15007. Doi: 10.1111/dme.15007.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetic Medicine 医学-内分泌学与代谢

CiteScore

7.20

自引率

5.70%

发文量

229

审稿时长

3-6 weeks

期刊介绍： Diabetic Medicine, the official journal of Diabetes UK, is published monthly simultaneously, in print and online editions. The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans. Categories of publication include research articles, reviews, editorials, commentaries, and correspondence. All material is peer-reviewed. We aim to disseminate knowledge about diabetes research with the goal of improving the management of people with diabetes. The journal therefore seeks to provide a forum for the exchange of ideas between clinicians and researchers worldwide. Topics covered are of importance to all healthcare professionals working with people with diabetes, whether in primary care or specialist services. Surplus generated from the sale of Diabetic Medicine is used by Diabetes UK to know diabetes better and fight diabetes more effectively on behalf of all people affected by and at risk of diabetes as well as their families and carers.”